Dr. Veerle Verjans Nefroloog - Orpadt
Dr. Veerle Verjans Nefroloog - Orpadt
Dr. Veerle Verjans Nefroloog - Orpadt
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Hba1c < 7% blijft niet<br />
Median HbA 1c (%)<br />
UKPDS<br />
9<br />
8.5<br />
8<br />
7.5<br />
7<br />
6.5<br />
6<br />
0<br />
Conventional*<br />
Glibenclamide<br />
Metformin<br />
Insulin<br />
Recommended<br />
treatment<br />
target 15 mmol/L; †ADA clinical practice recommendations. UKPDS<br />
34, n=1704<br />
UKPDS 34. Lancet 1998:352:854–65; Kahn et al. (ADOPT). NEJM 2006;355:2427–43<br />
8<br />
7.5<br />
7<br />
6.5<br />
6<br />
ADOPT<br />
0 1 2 3 4 5<br />
Time (years)<br />
Rosiglitazone<br />
Metformin<br />
Glibenclamide
Change language